Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Repair +/- Metformin for Cesarean Section Scar Defect
NCT05205317Recruiting
- Sponsor
- Xinhua Hospital
- Start
- Apr 2023
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of metformin in cesarean scar defect (CSD) (2 arms), sponsored by Xinhua Hospital. Primary endpoints: Duration of menstruation at 6 months and Thickness of the remaining muscular layer at 6 months. Started Apr 2023; status: recruiting.
02
Drugs
metformin
03
Conditions
cesarean scar defect (CSD)
Beyond the preview
Go deeper on NCT05205317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05205317.